Genin; Michael James
Patent Applications and Registrations
Patent applications and USPTO patent grants for Genin; Michael James.The latest application filed is for "[1,2,4]triazolo derivatives as pde1 inhibitors for the treatment of diabetes".
- Genin; Michael James - Danville IN
- Genin; Michael James - Zionsville IN
| Patent | Date |
|---|---|
| [1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes Grant 11,401,274 - Genin , et al. August 2, 2 | 2022-08-02 |
| [1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivatives Grant 11,180,503 - Genin , et al. November 23, 2 | 2021-11-23 |
| [1,2,4]triazolo Derivatives As Pde1 Inhibitors For The Treatment Of Diabetes App 20210147437 - Genin; Michael James ; et al. | 2021-05-20 |
| [1,2,4]triazolo[4,3-a]pyrazin-6(5h)-one Derivatives App 20200123154 - Genin; Michael James ; et al. | 2020-04-23 |
| Methods For Treating Kidney Disorders App 20170354645 - DEY; Asim Bikash ; et al. | 2017-12-14 |
| Compounds and methods for modulating FXR Grant 8,153,624 - Genin , et al. April 10, 2 | 2012-04-10 |
| Compounds and methods for modulating FXR Grant 8,106,077 - Bell , et al. January 31, 2 | 2012-01-31 |
| Compounds and methods for modulating FX-receptors Grant 7,863,302 - Bell , et al. January 4, 2 | 2011-01-04 |
| FXR agonists Grant 7,846,960 - Bell , et al. December 7, 2 | 2010-12-07 |
| Compounds And Methods For Modulating Fxr App 20100152166 - Genin; Michael James ; et al. | 2010-06-17 |
| Fxr Agonists App 20090270460 - Bell; Michael Gregory ; et al. | 2009-10-29 |
| Compounds And Methods For Modulating Fxr App 20090093524 - Bell; Michael Gregory ; et al. | 2009-04-09 |
| Compounds and Methods for Modulating Fx-Receptors App 20080306125 - Bell; Michael Gregory ; et al. | 2008-12-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 